An observational study in Cardiac Arrest, sponsored by University Hospital Pilsen. Active, not recruiting at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-09.
Sponsored by University Hospital Pilsen · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Heart Arrest with a site in Czechia — 7 open to participants now, 8 under way, none of them phase 3. Heart Arrest · Czechia.
Among the 15 studies in Heart Arrest with a site in Czechia, this one is the only one that started in 2021, is one of 7 observational ones, and was the 7th registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →7 of the 15 studies in Heart Arrest with a site in Czechia are open now. Recruiting first, the newest first:
Emergency Medical Service, Prague · Sites in Czechia
Ages 18–70
University Hospital Ostrava · Sites in Czechia
Ages 18–70
University Hospital Pilsen · Sites in Czechia
Ages 18–100
University Hospital Ostrava · Sites in Czechia
Ages 18–70
University Hospital Ostrava · Sites in Czechia
Ages 3–60
A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2021.
This study's planned enrollment of 80 is below the median of 200 across 376 observational studies indexed under Heart Arrest.
Median enrollment 168 across the 8 interventional studies, 80 across the 7 observational. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 15 have an industry lead sponsor. The 10 most frequent:
University Hospital Pilsen is the lead sponsor of 10 studies on the registry; 7 are open to participants now.
University Hospital Pilsen has 2 studies filed under Heart Arrest — fewer than ten, so there is no comparison to draw.
3 of the studies in Heart Arrest with a site in Czechia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04838418University Hospital PilsenTransorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest | 2026-12-01 |
| NCT07596446Emergency Medical Service, PragueFEMART-1 Pilot Study | 2026-12-31 |
| NCT07285915University Hospital PilsenThe Role of Stress in Cardiac Arrest (Cortizol CPR) | 2027-07-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Heart Arrest with a site in Czechia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In sudden cardiac arrest patients with return of spontaneous circulation, brain damage is one of the main determinants of short-term mortality and poor prognosis (CPC 3-5). It is important to properly select group of patients in whom treatment is futile. According to current guidelines, multimodal approach is recommended. Optic nerve sheath diameter measured by ultrasound is non-invasive, fast, low-cost and readily available bed-side method, but evidence for its use as neuroprognostication modality is limited to only few small studies. The aim of this study is to evaluate validity of ONSD as neuroprognostication method at larger cohort of patients, compare it with other established methods and compare ultrasound and CT measurement of ONSD.
Additional relevant MeSH terms:
cardiac arrest, cardiovascular diseases, optic nerve sheath diameter.
Male and female patients after cardiac arrest with subsequent ROSC, 18 years of age and older
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Optic nerve sheath diameter measured 3 mm behind eyeball. For every eyeball 2 measurements in axial and 2 measurements in sagital projections are performed. Summary value for every eyeball is arithmetic mean from these 4 measurements.
Value of ONSD for short-term neurological outcome prediction
Assessment of the correlation between the optic nerve sheath diameter measured by transorbital ultrasonography and neurological outcome of patients (quantified by the CPC scale) after out of hospital cardiac arrest with subsequent ROSC
Time frame: 30 days
Value of ONSD for short-term mortality prediction
Assessment of the correlation between optic nerve sheath diameter measured by transorbital ultrasonography and mortality during a 30-day follow-up.
Time frame: 30 days
Comparison of ONSD and electrophysiologic modalities for neurological outcome prediction
Assessment of the correlation between the optic nerve sheath diameter measured by transorbital ultrasonography and negative prognostic markers obtained by somatosensory evoked potentials examination and EEG in patients remaining in a coma even after the end of therapeutic hypothermia and sedation.
Time frame: 96 hours
Comparison of ONSD measurements by ultrasonography and computed tomography
Assessment of accuracy of the optic nerve sheath diameter measured by ultrasonography compared to CT measurement performed 48 ± 12 hours after achievment of ROSC.
Time frame: 48 hours
Correlation between ONSD and fundoscopic signs of papillary edema
Assessment of the correlation between the optic nerve sheath diameter measured by transorbital ultrasonography and grade of optic nerve papillary edema quantified by the Frisen scale on fundoscopic examination performed 48 ± 12 hours after achievment of ROSC.
Time frame: 48 hours
Correlation between ONSD and thickness of retinal nerve fibers measured by OCT
Assessment of the correlation between the optic nerve sheath diameter measured by transorbital ultrasonography and thickness of retinal nerve fibers measured by optical coherence tomography at time intervals of 1, 3 and 5 months after achievment of ROSC.
Time frame: 5 months
Effect of blood carbon dioxide on ONSD
Assessment of the correlation between the optic nerve sheath diameter measured by transorbital ultrasonography and paCO2 and ETCO2 values at the time of measurement.
Time frame: 72 hours
Value of ONSD for long-term neurological outcome and mortality
Assessment of the correlation between the optic nerve sheath diameter measured by transorbital ultrasonography and mortality and neurological outcome of patients (quantified by the CPC scale) at 6 months after ROSC.
Time frame: 6 months
Correlation between blood NSE, copeptin and selected RNAs
Assessment of the correlation between blood NSE, copeptin and selected micro-RNAs measured at defined time intervals from ROSC, to neurological outcome prediction in patients after out of hospital cardiac arrest with subsequent ROSC.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2021 (actual). Primary completion is estimated for Dec 2026, 70 months after the start.
Of 169 non-industry observational studies under Heart Arrest, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 96. This study's planned 70 months is above that.
Counting every sponsor, half of 176 studies reached it within 41 months; a quarter within 18 and three quarters within 90.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Pilsen